Taipei, Saturday, December 27, 2014 04:08 (GMT+8)
mostly cloudy
Taipei
16°C
PCB maker Apex to see capacity utilization rate drop to 80% in 4Q12 - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Thursday 11 October 2012]
  • APEX Medical
  • Performance
    The company's stock price closed at NT$63.5 on the TSE on Thursday, December 25, 2014.
    The company has reported consolidated revenues of NT$175 million for November 2014, representing a 6.3% drop on month and 22.7% increase on year.
    For the third quarter of 2014, the company totaled NT$555 million in consolidated revenues, down 5.1% sequentially and up 12.2% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    26-Dec 2,230 1,504 143,789,817 64.00 65.20 63.60 64.50+1.00+1.57% 64.60 64.50
    25-Dec 1,552 1,018 99,430,914 65.30 65.30 63.20 63.50-1.40-2.16% 63.60 63.50
    24-Dec 3,557 2,305 231,397,515 65.30 66.00 64.30 64.90-0.40-0.61% 65.00 64.80
    23-Dec 4,870 2,995 316,451,335 64.60 66.20 64.10 65.30+1.90+3.00% 65.40 65.30
    22-Dec 3,318 2,125 205,517,218 60.00 63.40 59.70 63.40+4.10+6.91% 0.00 63.40
    19-Dec 2,729 1,771 164,490,593 62.50 62.80 58.40 59.30-2.10-3.42% 59.40 59.20
    18-Dec 2,174 1,427 134,337,858 62.10 62.60 61.20 61.40+0.00+0.00% 61.50 61.40
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Nov 2013 - Nov 2014 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Nov-14

    175

    (6.3%)

    22.7%

    2,072

    16%

    Oct-14

    187

    (1%)

    7%

    1,905

    16%

    Sep-14

    189

    13.8%

    25%

    1,738

    18.4%

    Aug-14

    166

    (22.8%)

    5.2%

    1,535

    16.6%

    Jul-14

    215

    5.4%

    26.7%

    1,379

    19.1%

    Jun-14

    204

    (0.2%)

    40.3%

    1,177

    19%

    May-14

    205

    6.8%

    8.9%

    964

    14.4%

    Apr-14

    192

    (12.8%)

    16.9%

    760

    15.9%

    Mar-14

    220

    35.5%

    13.1%

    568

    15.6%

    Feb-14

    162

    (12.7%)

    18.5%

    348

    17.2%

    Jan-14

    186

    7%

    16%

    186

    16%

    Dec-13

    174

    21.5%

    6.5%

    1,959

    5.9%

    Nov-13

    143

    (18.2%)

    (0.1%)

    1,786

    5.8%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, December 2014

    Apex: Consolidated revenues, 3Q13 - 3Q14 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    3Q-14

    555

    (5.1%)

    12.2%

    1,721

    15%

    2Q-14

    585

    0.6%

    14.6%

    1,166

    16.4%

    1Q-14

    581

    11.6%

    18.3%

    581

    18.3%

    4Q-13

    521

    5.4%

    0.4%

    2,017

    9.3%

    3Q-13

    494

    (3.1%)

    17.5%

    1,496

    12.8%

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, December 2014

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 3Q13 - 3Q14 (NT$k)

    Item

    3Q-2014

    2Q-2014

    1Q-2014

    4Q-2013

    3Q-2013

    Current assets

    1,253,735

    1,316,636

    1,301,613

    1,078,245

    1,029,489

    Intangible assets

    558,078

    575,281

    580,933

    577,954

    572,223

    Non-current assets

    1,313,575

    1,332,685

    1,350,242

    1,351,082

    1,334,102

    Assets

    2,567,310

    2,649,321

    2,651,855

    2,429,327

    2,363,591

    Current liabilities

    637,837

    758,656

    739,553

    599,379

    606,240

    Non-current liabilities

    0

    0

    0

    143

    5,702

    Liabilities

    637,837

    758,656

    739,553

    599,522

    611,942

    Stockholders' equity

    1,929,473

    1,890,665

    1,912,302

    1,829,805

    1,751,649

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, December 2014

    Apex: Consolidated income statement, 3Q13 - 3Q14 (NT$k)

    Item

    3Q-2014

    2Q-2014

    1Q-2014

    4Q-2013

    3Q-2013

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

     

     

     

     

     

     

    521,003

     

    494,330

     

    Operating revenue

    554,834

    106.5%

    584,602

    112.2%

    581,195

    111.6%

    521,003

    100%

    494,330

    100%

    Gross profit (loss) from operations

    268,283

    51.5%

    266,062

    51.1%

    264,312

    50.7%

    231,525

    44.4%

    198,806

    40.2%

    Operating expenses

    202,629

    38.9%

    182,853

    35.1%

    195,434

    37.5%

    188,542

    36.2%

    175,425

    35.5%

    Operating income (loss)

    65,654

    12.6%

    83,209

    16%

    68,878

    13.2%

    42,983

    8.3%

    23,381

    4.7%

    Non-operating expenses and losses

    2,443

    0.5%

    -2,436

    -0.5%

    11,339

    2.2%

    9,361

    1.8%

    3,038

    0.6%

    Income from continuing operations before income tax

    68,097

    13.1%

    80,773

    15.5%

    80,217

    15.4%

    52,344

    10%

    26,419

    5.3%

    Net income (loss)

    51,340

    9.9%

    56,250

    10.8%

    60,610

    11.6%

    46,285

    8.9%

    15,086

    3.1%

    Diluted earnings per share (NT$)

    0.6

     

    0.6

     

    0.7

     

    0.5

     

    0.2

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, December 2014

  • APEX Medical full profile

26-Dec-2014 markets closed

 LastChange

TAIEX (TSE)9158.7-27.48-0.3% 

TSE electronic363.54-1.16-0.32% 

GTSM (OTC)137.3-0.18-0.13% 

OTC electronic175.13+0.13+0.07% 

Advantest
Analysis of China revised domestic semiconductor industry goals
Trends and developments in the OTT market
  • Wireless broadband developments in Southeast Asia markets

    As of 2013, the 10 ASEAN nations had a total of over 700 million mobile subscriptions, with the CAGR from 2003-2013 reaching 24%. This Digitimes Research Special Report analyzes the various mobile broadband markets in ASEAN and looks at the respective trends in 4G LTE development for those markets.

  • Greater China touch panel shipment forecast through 2015

    This Special Report provides forecasts through 2015 for Greater China touch panel shipments with breakdowns based on technology (glass, film, resistive), application (smartphone, NB and tablet) and by firm.

  • 2014 global tablet demand forecast

    This report analyzes the main players, their strategies and shipments forecasts for 2014, as well as other factors contributing to either growth or decline in various segments within the tablet market, with a particular focus on Apple, Google, Samsung, and Microsoft, along with whitebox vendors.